Table 1. Clinical characteristics between CAD and control groups.

Characteristics	CAD(n = 706)	Controls(n = 315)	P
Male [n(%)]	507 (71.81%)	142 (45.08%)	<0.001
Age (years)	63.72 ± 10.03	58.85 ± 9.50	<0.001
EH [n(%)]	487 (68.98%)	180 (57.14%)	<0.001
DM [n(%)]	185 (26.20%)	31 (9.84%)	<0.001
Smoking [n(%)]	231 (32.72%)	61 (19.37%)	<0.001
Statin use [n(%)]	57 (8.07%)	6 (1.90%)	<0.001
TC (mmol/l)	4.55± 1.00	4.50± 0.94	0.407
TG (mmol/l)	1.87± 1.33	1.77± 1.27	0.021
HDL-C (mmol/l)	1.07± 0.27	1.20± 0.35	<0.001
LDL-C (mmol/l)	2.80± 0.87	2.58± 0.70	<0.001
Apo A1 (g/L)	1.20± 0.26	1.26± 0.24	<0.001
Apo B (g/L)	0.94± 0.28	0.89± 0.29	0.009
Lp (a) (g/L)	0.24± 0.27	0.22± 0.29	0.309
CAG [n(%)]	669 (94.76%)	307 (97.46%)	0.052

CAD, coronary artery disease; EH, essential hypertension; DM, diabetes mellitus; TC, total cholesterol; TG, triacylglycerols; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; CAG, coronary angiogram; Apo, apolipoprotein.